Late Breaking Abstract - Phase 1 dose escalation study of aerosolized pirfenidone in normal healthy volunteers (NHV), smokers, and IPF patients

Mapping Intimacies ◽

10.1183/13993003.congress-2018.oa266 ◽

2018 ◽

Cited By ~ 1

Author(s):

Alan Montgomery ◽

Kelly Otto ◽

Jun Khoo ◽

Ian Glaspole

Keyword(s):

Healthy Volunteers ◽

Dose Escalation ◽

Phase 1 ◽

Dose Escalation Study

Download Full-text

A Phase 1, Randomised, Placebo-Controlled, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Cannabidiol in Fed Healthy Volunteers

European Journal of Drug Metabolism and Pharmacokinetics ◽

10.1007/s13318-020-00624-6 ◽

2020 ◽

Vol 45 (5) ◽

pp. 575-586 ◽

Cited By ~ 2

Author(s):

Daniel Perkins ◽

Juliet Butler ◽

Katherine Ong ◽

Tri-Hung Nguyen ◽

Susan Cox ◽

...

Keyword(s):

Healthy Volunteers ◽

Dose Escalation ◽

Phase 1 ◽

Dose Escalation Study

Download Full-text

Phase 1 Dose‐Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.741 ◽

2019 ◽

Vol 9 (1) ◽

pp. 11-20 ◽

Cited By ~ 2

Author(s):

So Miyoshi ◽

Sriram Krishnaswami ◽

Shigeyuki Toyoizumi ◽

Hiroyuki Nakamura ◽

Samuel H. Zwillich

Keyword(s):

Healthy Volunteers ◽

Dose Escalation ◽

Phase 1 ◽

Dose Escalation Study

Download Full-text

Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China

Case Medical Research ◽

10.31525/ct1-nct03998345 ◽

2019 ◽

Author(s):

Keyword(s):

Dose Escalation ◽

Phase 1 ◽

Open Label ◽

Dose Escalation Study ◽

Label Dose

Download Full-text

Faculty Opinions recommendation of Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955175.793461372 ◽

2012 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Liver Metastases ◽

Dose Escalation ◽

Phase 1 ◽

Dose Escalation Study

Download Full-text

P2-476: A Phase 1, dose escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple oral daily doses of ELND006 in healthy elderly subjects

Alzheimer s & Dementia ◽

10.1016/j.jalz.2011.05.1347 ◽

2011 ◽

Vol 7 ◽

pp. S465-S465 ◽

Cited By ~ 3

Author(s):

Earvin Liang ◽

Wenzhong Jerry Liu ◽

Lisa Lohr ◽

Van Nguyen ◽

Holly Lin ◽

...

Keyword(s):

Dose Escalation ◽

Phase 1 ◽

Elderly Subjects ◽

Pharmacokinetics And Pharmacodynamics ◽

Dose Escalation Study ◽

Healthy Elderly ◽

Healthy Elderly Subjects

Download Full-text

Inhibition of Complement C3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results

American Journal of Ophthalmology ◽

10.1016/j.ajo.2021.08.018 ◽

2021 ◽

Author(s):

Charles C. Wykoff ◽

Vrinda Hershberger ◽

David Eichenbaum ◽

Erin Henry ◽

Husam S. Younis ◽

...

Keyword(s):

Dose Escalation ◽

Phase 1 ◽

Geographic Atrophy ◽

Complement C3 ◽

Dose Escalation Study ◽

Study Results

Download Full-text

Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study

EClinicalMedicine ◽

10.1016/j.eclinm.2021.100989 ◽

2021 ◽

pp. 100989

Author(s):

Szu-Min Hsieh ◽

Wang-Da Liu ◽

Yu-Shan Huang ◽

Yi-Jiun Lin ◽

Erh-Fang Hsieh ◽

...

Keyword(s):

Aluminum Hydroxide ◽

Dose Escalation ◽

Phase 1 ◽

Healthy Adults ◽

Spike Protein ◽

Protein Vaccine ◽

Dose Escalation Study

Download Full-text

Phase 1 Dose-Escalation Study of CP-690 550 in Stable Renal Allograft Recipients: Preliminary Findings of Safety, Tolerability, Effects on Lymphocyte Subsets and Pharmacokinetics

American Journal of Transplantation ◽

10.1111/j.1600-6143.2008.02307.x ◽

2008 ◽

Vol 8 (8) ◽

pp. 1711-1718 ◽

Cited By ~ 56

Author(s):

E. van Gurp ◽

W. Weimar ◽

R. Gaston ◽

D. Brennan ◽

R. Mendez ◽

...

Keyword(s):

Dose Escalation ◽

Renal Allograft ◽

Lymphocyte Subsets ◽

Phase 1 ◽

Dose Escalation Study

Download Full-text

Abstract CT015: A phase 1 dose escalation study of TB-403 in pediatric relapsed or refractory medulloblastoma, neuroblastoma, Ewing sarcoma, or alveolar rhabdomyosarcoma

10.1158/1538-7445.am2021-ct015 ◽

2021 ◽

Author(s):

Giselle L. Saulnier Sholler ◽

Dan G. Duda ◽

Genevieve Bergendahl ◽

David Ebb ◽

Matija Snuderl ◽

...

Keyword(s):

Dose Escalation ◽

Ewing Sarcoma ◽

Phase 1 ◽

Alveolar Rhabdomyosarcoma ◽

Dose Escalation Study

Download Full-text

Abstract CT111: Results of a phase 1 dose escalation study of ERY974, an anti-glypican 3 (GPC3)/CD3 bispecific antibody, in patients with advanced solid tumors

10.1158/1538-7445.am2021-ct111 ◽

2021 ◽

Author(s):

Howard Safran ◽

Mihaela Druta ◽

Michael Morse ◽

Filipa Lynce ◽

Sofya Pintova ◽

...

Keyword(s):

Solid Tumors ◽

Dose Escalation ◽

Bispecific Antibody ◽

Phase 1 ◽

Advanced Solid Tumors ◽

Dose Escalation Study

Download Full-text